698 reports of this reaction
2.6% of all KETOCONAZOLE CREAM, 2% reports
#5 most reported adverse reaction
RASH is the #5 most commonly reported adverse reaction for KETOCONAZOLE CREAM, 2%, manufactured by Encube Ethicals, Inc.. There are 698 FDA adverse event reports linking KETOCONAZOLE CREAM, 2% to RASH. This represents approximately 2.6% of all 27,109 adverse event reports for this drug.
Patients taking KETOCONAZOLE CREAM, 2% who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH is a less commonly reported adverse event for KETOCONAZOLE CREAM, 2%, but still significant enough to appear in the safety profile.
In addition to rash, the following adverse reactions have been reported for KETOCONAZOLE CREAM, 2%:
The following drugs have also been linked to rash in FDA adverse event reports:
RASH has been reported as an adverse event in 698 FDA reports for KETOCONAZOLE CREAM, 2%. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH accounts for approximately 2.6% of all adverse event reports for KETOCONAZOLE CREAM, 2%, making it a notable side effect.
If you experience rash while taking KETOCONAZOLE CREAM, 2%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.